Treating EGFR mutation resistance in non-small cell lung cancer – role of osimertinib

Valentina Mazza, Federico Cappuzzo
  • The Application of Clinical Genetics, July 2017, Dove Medical Press
  • DOI: 10.2147/tacg.s103471

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/tacg.s103471

The following have contributed to this page: Dr Federico Cappuzzo